ÂÜÀòÂÒÂ×

Suenell Broyer currently serves as Sr. Director of Medical Affairs at ClinChoice, a position held since September 2022. Prior experience includes serving as Principal Regulatory and Medical Writer at Broyer Consultants from August 2011 to September 2022, where responsibilities entailed regulatory and medical writing for a variety of clients including academia and the biotech sector. Broyer held significant roles in regulatory affairs at various organizations, including Director of Regulatory Affairs at Juno Therapeutics, where involvement included strategic regulatory submissions for CAR-T cell therapies, and as Sr. Director of Regulatory and Clinical Affairs at ZetaRx Biosciences, focusing on cellular therapies. Earlier roles included Director of Regulatory Writing and Submissions at City of Hope, overseeing regulatory activities for active INDs, and Sr. Manager of Regulatory Affairs at Elan Pharmaceuticals, managing IND submissions. Broyer began a career in regulatory operations at Quintiles, Inc. with a focus on IND and NDA submissions across North America and Europe. Broyer holds a BA in Sociology from UCLA.